Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $269.45 | Total: $1,347.25 |
| 1 | 10 | $228.24 | Total: $2,282.40 |
| 1 | 25 | $193.37 | Total: $4,834.25 |
| 1 | 50 | $164.84 | Total: $8,242.00 |
| 1 | 100 | $142.65 | Total: $14,265.01 |
Overview
Taprizosin?UK-338003? is a selective and orally active ?1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
Chemical Properties
| Molecular Formula | C25H26N6O4S |
| Molecular Weight | 506.58 |
| CAS Numbers | 210538-44-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | NC=1C=2C(=C(OC)C(OC)=CC2N=C(N1)N3CC=4C(CC3)=C(NS(C)(=O)=O)C=CC4)C5=CC=CC=N5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Collett A, et al. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-[5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl]-5-[2-pyridyl]quinazoline [UK-338,003] the rational use of ex vivo intestine to predict in vivo absorption. Drug Metab Dispos. 2008 Jan;36[1] 87-94.